Atlas Trials

Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI)

Clinical trial NCT06144255 · COMPLETED

Trial details

NCT number
NCT06144255
Sponsor
Florian Schmitzberger
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2023-11-17
Primary completion
2024-02-22
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.